腺瘤检出率影响低风险患者异时性进展期结直肠肿瘤的风险
研究纳入7171例首次筛查结肠镜无腺瘤或1-2个非进展期腺瘤者,分析内镜医师腺瘤检出率(ADR)与异时性进展期结直肠肿瘤(AN)风险的关系。多因素分析显示ADR每升高1.0%,异时性AN风险降低3.0%(调整OR .97,95%CI .95-.99);ADR≥32%者风险降低(调整OR .53,95%CI .35-.83)。
要点
- ADR每升高1.0%,异时性AN风险降低3.0%(调整OR .97,95%CI .95-.99)。
- 内镜医师ADR≥32%者异时性AN风险降低(调整OR .53,95%CI .35-.83)。
- ADR对异时性AN的影响在低风险腺瘤患者显著,而非无腺瘤患者。
核心结论
- 在低风险腺瘤患者中,内镜医师的ADR与异时性AN风险呈负相关。
研究设计与样本
- 识别7171例首次筛查结肠镜无腺瘤或1-2个非进展期腺瘤的参与者,在监测结肠镜时分析异时性AN风险。
主要发现
- 多因素分析显示异时性AN风险与年龄增长、男性、腺瘤数目增多及内镜医师ADR强相关。
- ADR作为连续变量,每升高1.0%,异时性AN风险降低3.0%(调整OR .97,95%CI .95-.99)。
- 以32%为二分类切点,内镜医师ADR≥32%的患者异时性AN风险降低(调整OR .53,95%CI .35-.83)。
- 与最低三分位ADR的内镜医师患者相比,最高三分位ADR的内镜医师患者异时性AN风险降低(调整OR .66,95%CI .46-.95)。
- ADR对异时性AN的影响在低风险腺瘤患者显著,而非无腺瘤患者。
关键数值与推荐
- ADR每升高1.0%,异时性AN风险降低3.0%(调整OR .97,95%CI .95-.99)。
- 内镜医师ADR≥32%者异时性AN风险降低(调整OR .53,95%CI .35-.83)。
- 最高三分位ADR者异时性AN风险降低(调整OR .66,95%CI .46-.95)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: In individuals with either no or 1 to 2 nonadvanced adenomas, future risks of advanced colorectal neoplasia (AN) vary according to clinical risk factors. However, little is known about the association between the adenoma detection rate (ADR) and the risk for metachronous AN in patients with low-risk adenomas. METHODS: We identified 7171 participants with no or 1 to 2 nonadvanced adenomas at first-time screening colonoscopy. The risk of metachronous AN was investigated at surveillance colonoscopy, according to clinical characteristics and the ADR. RESULTS: In multivariate analysis the risk for metachronous AN was strongly associated with increasing age, male sex, increasing number of adenomas, and the ADR of the endoscopist. With the ADR modeled as a continuous variable, each 1.0% increase in the rate of ADR predicted a 3.0% decrease in the risk of metachronous AN (adjusted odds ratio [OR], .97; 95% confidence interval [CI], .95-.99). With the ADR modeled using a binary cut-off (32%), the risk of metachronous AN was reduced in patients of endoscopists with an ADR ≥32% (adjusted OR, .53; 95% CI, .35-.83). Moreover, the risk of metachronous AN was reduced (adjusted OR, .66; 95% CI, .46-.95) in patients of endoscopists with an ADR in the highest tertile, compared with patients of endoscopists with ADRs in the lowest tertile. The impact of ADR on metachronous AN was significant for patients with low-risk adenomas rather than patients with no adenoma. CONCLUSIONS: In patients with low-risk adenomas, the ADR of the endoscopist was inversely associated with the risk of metachronous AN.
引用
- Kim TJ, Kim ER, Hong SN, et al. Adenoma detection rate influences the risk of metachronous advanced colorectal neoplasia in low-risk patients. Gastrointest Endosc. 2017. PMID: 28987544. doi:10.1016/j.gie.2017.09.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。